PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.\', \'NewYork-Presbyterian Hospital, Weill Cornell Medical Campus, New York, New York, USA.\', \'Department of Population Health Sciences, Weill Cornell Medicine, New York, New York, USA.\', \'School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.\', \'Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.\', \'Departments of Laboratory Medicine and Pathology at Hennepin Healthcare/Hennepin County Medical Center and University of Minnesota, Minneapolis, Minnesota, USA.\', \'Department of Biomedical Engineering, Shenzhen Research Institute, Beijing University of Chinese Medicine, Shenzhen, China.\', \'Department of Radiation Oncology and.\', \'Department of Medicine, Weill Cornell Medicine, New York, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1172/jci.insight.151477e151477
?:hasPublicationType
?:journal
  • JCI insight
is ?:pmid of
?:pmid
?:pmid
  • 34499052
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all